Latest Breaking News On - United states adopted name - Page 1 : vimarsana.com

Lisata Therapeutics, Inc (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript

Lisata Therapeutics, Inc (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesNew south walesNew zealandJohn mendittoRobert leboyerPete enderlinErkki ruoslahtiDavid mazzoJames niscoRobert sassoonJoseph pantginisSteve brozakSara nikTherapeutic goods administrationClinical trial centerTherapeutic goods regulatory agency of the australian

Marker Therapeutics Reports Year-End 2023 Corporate and

Lead program in patients with lymphoma demonstrated preliminary safety and efficacy results with sustained complete response in first study participant.

United statesLincoln parkDaniel kontoh boatengJuan veraInternational nonproprietary namesSmall business innovation researchEuropean medicines agencyCompany principal financialNational institute of healthCommittee for orphan medicinal productsMaster services agreement for productExpert committeeMarker therapeutics incDrug administrationNational instituteAcute myeloid leukemia

Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results

Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesLincoln parkJuan veraDaniel kontoh boatengCompany principal financialNational institute of healthExpert committeeInternational nonproprietary namesCommittee for orphan medicinal productsMaster services agreement for productEuropean medicines agencySmall business innovation researchDrug administrationMarker therapeutics incNational instituteAcute myeloid leukemia

Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer s at the AD/PD™ 2024 Annual Meeting -February 21, 2024 at 08:02 am EST

- Oral presentation to explore drug effect of sabirnetug on key cerebrospinal fluid biomarkers in early AD - Poster presentation to showcase method used to develop a first-of-its-kind assay.

United statesErika clineDaniel oconnellJessica laubAlex braunInternational nonproprietary namesExchange commissionAcumen pharmaceuticalsInternational conference on alzheimerDrug administrationDrug developmentAcumen pharmaceuticals incUnited states adopted nameInternational conferenceDanielo connellChief executive officer

Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress

Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBarry greeneMatthew hensonAshley kaplowitzSteering groupRegulatory agencyExchange commissionUs drug enforcement administrationNational pregnancy registry for antidepressantsBiogen incEuropean medicines agencySage therapeutics incDrug administrationChief executive officerEnforcement administration